Survivors (n = 210) | Non-survivors (n = 118) | p (survivors vs. non-survivors) | |
---|---|---|---|
Median age | 64 [54;73] | 62 [55;69] | 0.319 |
Males | 128/210 (61.0%) | 79/118 (66.9%) | 0.280 |
Median BMI | 25.0 [22;29] | 24.0 [21.75;28] | 0.248 |
APACHE II score | 26.6 ± 8.1 | 28.0 ± 7.6 | 0.110 |
SOFA score | 7.6 ± 3.9 | 10.1 ± 3.9 | < 0.001 |
Sepsis focus | |||
Pulmonary | 102/210 (48.6%) | 84/118 (71.2%) | < 0.001 |
Urinary tract | 42/210 (20.0%) | 10/118 (8.5%) | 0.006 |
Abdomen | 18/210 (8.6%) | 11/118 (9.3%) | 0.818 |
Vascular access | 16/210 (7.6%) | 0/118 (0%) | 0.002 |
Skin and soft tissue | 6/210 (3.3%) | 3/118 (1.7%) | 0.867 |
Endocarditis | 4/210 (1.9%) | 2/118 (1.7%) | 0.892 |
Others | 22/210 (10.5%) | 8/118 (6.8%) | 0.265 |